A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

Clinical trial NCT02147197 · COMPLETED

Trial details

NCT number: NCT02147197
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leiomyoma Uterine Hemorrhage

Start date: 2014-03-31
Primary completion: 2016-03-29
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.